Pär Ingemar Johansson

Medicine & Life Sciences

1. Thrombelastography 100%
2. Wounds and Injuries 64%
3. Hemostatics 61%
4. Hemorrhage 56%
5. Blood Platelets 50%
6. Syndecan-1 49%
7. Resuscitation 37%
8. Glycocalyx 36%
9. Mortality 35%
10. Biomarkers 29%
11. Thrombomodulin 29%
12. recombinant FVIIa 26%
13. Erythrocytes 25%
14. Fibrinogen 22%
15. Randomized Controlled Trials 20%
16. Shock 17%
17. Sepsis 17%
18. Erythrocyte Transfusion 17%
19. Traumatic Brain Injury 16%
20. Hemostasis 16%
21. Prospective Studies 16%
22. Observational Studies 15%
23. Out-of-Hospital Cardiac Arrest 15%
24. Epoprostenol 14%
25. Iloprost 14%
26. Hemoglobins 13%
27. Placebos 13%
28. Septic Shock 13%
29. Intensive Care Units 12%
30. Hemorrhagic Shock 12%
31. Blood Transfusion 12%
32. Fibrinolysis 11%
33. Critical Illness 11%
34. Endothelial Cells 11%
35. Epinephrine 11%
36. Coronary Artery Bypass 11%
37. Hip 11%
38. Platelet Count 11%
39. Therapeutics 10%
40. Trauma Centers 10%
41. Catecholamines 10%
42. Thrombophilia 9%
43. Cohort Studies 9%
44. Endothelium 9%
45. Post-Cardiac Arrest Syndrome 9%
46. Arthroplasty 9%
47. Multicenter Studies 8%
48. Percutaneous Coronary Intervention 8%
49. Mental Competency 8%
50. Injury Severity Score 8%